The role of magnesium in a complex prevention of gestosis and fetoplacental insufficiency
Deficiency of magnesium is associated with a wide range of complications of pregnancy, childbirth and fetal pathologies: enhanced incidence of gestosis, preterm labor, fetal maldevelopments and others. The objective of the present study was to assess the efficacy of a complex drug-based prevention of gestosis using the drug Magne B6 in pregnant women from a high risk group. The examination included 250 patients from a high risk group for development of gestosis. The results of the study show that Magne B6 promotes optimization of the state of the fetoplacental system, arresting the progress of disorders that are present in the system «mother-placenta-fetus». Prevention and therapy of gestosis by the drug Magne B6 permits to significantly decrease the incidence and severity of gestosis and FPI, suspend the development of the first clinical signs of gestosis and FPI by 2-4 wks on the average, improve outcomes of pregnancy, childbirth and the condition of the neonate.